REFERENCES
- Freis, E. D.: Observations on cardiac output, peripheral blood flow and blood volume in hypertension before and during treatment. In Moyer, J. H. (Editor): The First Hahnemann Symposium on Hypertensive Disease. Philadelphia, W. B. Saunders Company, 1959, p. 123.
- Dollery, C. T., Emslie-Smith, D. and Shilling-Ford, J. P.: Hemodynamic effects of guanethidine. Lancet 2: 331, 1961.
- Bjork, S., Sannerstedt, R., Angervall, G. and Hood, B.: Treatment and prognosis in malignant hypertension. Acta med. scandinav. 166: 175, 1960.
- Carlsson, A., Rosengren, E., Bertler, A. and Nilsson, J.: Effect of reserpine on the metabolism of catechol amines. In Garratini, S. and Ghetti, V. (Editors): International Symposium on Psychotropic Drugs. Amsterdam, Netherlands, Elsevier Publishing Co., 1957, p. 363.
- Cass, R. and Spriggs, T. L. B.: Tissue amine levels and sympathetic blockade after guanethidine and bretylium. Brit. J. Pharmacol. 17: 442, 1961.
- Sjoerdsma, A., Oates, J. A. and Gillespie, L., Jr.: Quantitation of monoamine oxidase inhibition produced with various drugs in man. Proc. Soc. Exper. Biol. & Med. 103: 485, 1960.
- Holdsworth, C. D., Atkinson, M. and Goldie, W.: Hepatitis caused by the newer amine-oxidase-inhibiting drugs. Lancet 2: 621, 1961.
- Horwitz, D. and Sjoerdsma, A.: A nonhydrazine monoamine oxidase inhibitor with antihypertensive properties. Proc. Soc. Exper. Biol. & Med. 106: 118, 1961.
- Oates, J. A., Gillespie, L., Jr., Udenfriend, S. and Sjoerdsma, A.: Decarboxylase inhibition and blood pressure reduction by α-methyl-3,4-dihydroxy-DL-phenylalanine. Science 131: 1890, 1960.
- Gillespie, L., Jr., Oates, J. A., Crout, J. R. and Sjoerdsma, A.: Clinical and chemical studies with α-methyldopa in patients with hypertension. Circulation 25: 281, 1962.
- Sjoerdsma, A.: Relationships between alterations in amine metabolism and blood pressure. Circulation Res. 9: 734, 1961.
- Sjoerdsma, A.: Alpha-methyldopa, antihypertensive drug with an unusual mechanism of action. Heart Bull. 12: 1, 1963.